Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 60 years or younger, of any sex
- People who have been diagnosed with diffuse large B-cell lymphoma (a specific type of blood cancer) confirmed through tissue and laboratory testing, and who have not yet received any treatment for it
- People whose cancer is limited to the central nervous system (the brain and spinal cord), with no signs of it spreading to other parts of the body, based on physical examination, imaging, and blood tests
- People whose diagnosis meets the specific criteria for Primary Central Nervous System Lymphoma (a lymphoma that starts in the brain or spinal cord)
- People who have provided written consent to take part, or whose legal guardian has done so on their behalf
- People who are willing to participate in the study voluntarily
Who may not be able to join:
- People who have another active cancer diagnosis at the same time
- People with a known history of HIV infection or AIDS
- People with a known allergy to any of the study drugs or their ingredients
- People with serious other health conditions, significant abnormal laboratory results, or difficult personal or family circumstances that, in the opinion of the treating doctor, could affect safety or the ability to complete the study (confirm with trial site for details)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Objective Response Rate (ORR)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.